We recently published a list of Why These 10 Stocks Soared Today. In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other Wednesday’s best-performing stocks. The stock market rebounded on Wednesday, with all major indices ending in the green as investors cheered the Federal Reserve’s decision to keep interest rates unchanged. On Wednesday afternoon, the Fed kept rates steady at a range of 4.25 percent to 4.5 percent, saying that it was not in a hurry to cut rates and could still “wait and see” the impact of President Donald Trump’s tariff policies. The Dow Jones rallied by 0.70 percent, the S&P 500 increased by 0.43 percent, and the Nasdaq grew by 0.27 percent. Beyond the major indices, 10 firms stood out with strong gains, thanks to a flurry of fresh developments, including new partnerships, optimistic outlooks, and impressive earnings performance. In this article, we name Wednesday’s 10 best-performing stocks and detail the reasons behind their gains. To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.Why Oscar Health, Inc. (OSCR) Skyrocketed On Wednesday A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. Oscar Health, Inc. (NYSE:OSCR) Oscar Health skyrocketed by 30.22 percent on Wednesday to close at $17.02 per share after reporting a strong earnings performance in the past quarter. During the period, Oscar Health, Inc. (NYSE:OSCR) said it achieved a 55-percent increase in net income attributable to the company, at $275 million versus the $177 million in the same period last year. Revenues were also higher by 42 percent to $3.05 billion from $2.14 billion year-on-year. During the quarter, its membership increased by 40.7 percent to 2.04 million from 1.4 million in the same period a year ago. “We continue to expect meaningful margin expansion this year as we deliver superior value to our members and partners,” said Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini, adding that the company has reaffirmed its full year 2025 outlook across all metrics. Oscar Health, Inc. (NYSE:OSCR) expects revenues between $11.2 billion and $11.3 billion and operational earnings of $225 million to $275 million. Overall, OSCR ranks 1st on our list of Wednesday’s best-performing stocks. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than OSCR but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. Story Continues READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. View Comments
Why Oscar Health, Inc. (OSCR) Skyrocketed On Wednesday
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...